Computational assay of Zanamivir binding affinity with original and mutant influenza neuraminidase 9 using molecular docking

Journal of Theoretical Biology
Khac-Minh ThaiMinh-Tri Le

Abstract

Based upon molecular docking, this study aimed to find notable in silico neuraminidase 9 (NA9) point mutations of the avian influenza A H7N9 virus that possess a Zanamivir resistant property and to determine the lead compound capable of inhibiting these NA9 mutations. Seven amino acids (key residues) at the binding site of neuraminidase 9 responsible for Zanamivir-NA9 direct interactions were identified and 72 commonly occurring mutant NA9 versions were created using the Sybyl-X 2.0 software. The docking scores obtained after Zanamivir was bound to all mutant molecules of NA9 revealed 3 notable mutations R292W, R118P, and R292K that could greatly reduce the binding affinity of the medicine. These 3 mutant NA9 versions were then bound to each of 154 different molecules chosen from 5 groups of compounds to determine which molecule(s) might be capable of inhibiting mutant neuraminidase 9, leading to the discovery of the lead compound of potent mutant NA9 inhibitors. This compound, together with other mutations occurring to NA9 identified in the study, would be used as data for further research regarding neuraminidase inhibitors and synthesizing new viable medications used in the fight against the virus.

References

Jun 1, 1989·Trends in Biochemical Sciences·K C Chou
Nov 1, 1988·Biopolymers·K C Chou, B Mao
Jun 11, 1999·Biochemical and Biophysical Research Communications·K C ChouR L Heinrikson
Dec 11, 1999·Nucleic Acids Research·H M BermanP E Bourne
Apr 4, 2000·FEBS Letters·K C ChouR L Heinrikson
Mar 12, 2003·Bioorganic & Medicinal Chemistry·Xiang YiFeng Ming Chu
Apr 2, 2004·Journal of Medicinal Chemistry·Pooran ChandTsu-Hsing Lin
Jul 29, 2004·Current Medicinal Chemistry·Kuo-Chen Chou
May 2, 2006·Biochemical and Biophysical Research Communications·Dong-Qing WeiKuo-Chen Chou
Feb 3, 2007·Biochemical and Biophysical Research Communications·Shu-Qing WangKou-Chen Chou
Aug 21, 2007·Biochemical and Biophysical Research Communications·Qi-Shi DuKuo-Chen Chou
Apr 22, 2009·Protein Engineering, Design & Selection : PEDS·Jing-Fang WangKuo-Chen Chou
Apr 23, 2009·Proceedings of the National Academy of Sciences of the United States of America·Rafal M PielakJames J Chou
Oct 13, 2009·Biochemical and Biophysical Research Communications·Jing-Fang Wang, Kuo-Chen Chou
May 11, 2010·Biochimica Et Biophysica Acta·Rafal M Pielak, James J Chou
Jun 24, 2010·Protein Engineering, Design & Selection : PEDS·Jing-Fang Wang, Kuo-Chen Chou
Sep 14, 2010·Biochemical and Biophysical Research Communications·Rafal M Pielak, James J Chou
Mar 26, 2013·Antiviral Research·Mélanie SamsonGuy Boivin
Oct 29, 2013·Biology Direct·Raphael Tze Chuen LeeSebastian Maurer-Stroh
Dec 21, 2013·Scientific Reports·Christopher J WoodsAdrian J Mulholland

❮ Previous
Next ❯

Citations

Feb 15, 2018·Molecules : a Journal of Synthetic Chemistry and Natural Product Chemistry·Ming HongWeiwei Xing
Jun 18, 2017·Interdisciplinary Sciences, Computational Life Sciences·Hemant AryaMohane Selvaraj Coumar
Sep 13, 2019·International Journal of Molecular Sciences·Yusra Sajid KianiAdrian J Mulholland
May 5, 2020·ACS Omega·Bui Thi Phuong ThuyNguyen Thi Ai Nhung

❮ Previous
Next ❯

Related Concepts

Related Feeds

Antivirals (ASM)

Antivirals are medications that are used specifically for treating viral infections. Discover the latest research on antivirals here.

Antivirals

Antivirals are medications that are used specifically for treating viral infections. Discover the latest research on antivirals here.